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ABSTRACT  
Background: Polypharmacy (≥ 5 medications) is common in older people and is associated with 
adverse outcomes. Patients' beliefs about medication can influence patients’ expectations for 
medication, adherence, and willingness to deprescribe.  Few studies have examined beliefs about 
prescribed medication among older patients with polypharmacy in primary care.    
 
Aim: To explore medication related beliefs in older people with polypharmacy and factors which 
might influence beliefs.  
 
Design and Setting: Mixed methods study utilising data from a randomised controlled trial aiming to 
decrease potentially inappropriate prescribing in older patients (≥ 70 years) in Ireland. 
 
Method: Beliefs were assessed quantitatively and qualitatively. Participants completed the Beliefs 
about Medicines Questionnaire (BMQ) by indicating their degree of agreement with individual 
statements about medicines on a 5 point Likert scale. Semi-structured qualitative interviews were 
conducted with a purposive sample of participants. Interviews were transcribed verbatim and a 
thematic analysis conducted. Quantitative and qualitative data were analysed separately and 
triangulated during the interpretation stage.   
 
Results: 196 patients were included (mean age 76.7 years, SD 4.9, 54% male), with a mean of 9.5 (SD 
4.1) medications per person. The majority (96.3%) believed strongly in the necessity of their 
medication while 33.9% reported strong concerns.  Qualitative data confirmed these co-existing 
positive and negative attitudes to medications and suggested the importance of patients’ trust in 
GPs in establishing positive beliefs and potential willingness to deprescribe.     
 
Conclusions: Participants reported strong beliefs in medications with co-existing positive and 
negative attitudes. The patient–doctor relationship may have influenced beliefs and attitudes 
towards medicines, highlighting the importance of strong patient–doctor relationships which need 
to be considered in the context of deprescribing.   
 
 
Keywords: Polypharmacy, older patients, beliefs, primary care, qualitative analysis, mixed methods 
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How this fits in 
Inappropriate polypharmacy in older patients imposes a significant burden and may lead to 
adverse drug events, poor adherence, and geriatric syndromes. Consequently, there has 
been an increased emphasis on deprescribing and interventions to improve the appropriate 
use of polypharmacy. Patients’ strong beliefs in medicines are often reported as important 
barriers to deprescribing by GPs. However, beliefs about medication in patients with 
polypharmacy have scarcely been investigated. Using qualitative and quantitative data this 
study explored patients’ beliefs about and attitudes towards medication, within a 
population of community dwelling older patients with polypharmacy. Study participants 
reported strong beliefs in medications with co-existing positive and negative attitudes. 
Patient–doctor trust may have influenced beliefs and attitudes towards medicines, 
highlighting the importance of strong patient–doctor relationships in the context of 
deprescribing.   
 
4 
 
INTRODUCTION 
Polypharmacy (prescribing of many drugs (appropriately) or too many drugs (inappropriately)) is 
common in older people. (1, 2) The prevalence of polypharmacy (≥ 5 medications) increased from 
17.8% in 1997 to 60.4% in 2012 in persons aged ≥ 65 in Ireland, and doubled to 20.8% between 1995 
and 2010 in Scotland. (3, 4) Polypharmacy is associated with adverse drug reactions, poor 
medication adherence, geriatric syndromes (e.g. urinary incontinence), potentially inappropriate 
prescribing (medications where their risks outweigh the benefits and when a safer alternative is 
available) and increased drug expenditure.(5-8) Consequently, there has been an increased 
emphasis on deprescribing (process of medication cessation) and interventions to improve the 
appropriate use of polypharmacy such as medication reviews delivered by clinical pharmacists.(9)   
 
Patients' beliefs about treatment are an important influence on prescription medication use. 
Patients may influence prescribing decisions on the basis of their expectations or reluctance to take 
medicines in some cases. Patients’ strong beliefs in medicines, expectations, and resistance to 
change are often cited as important barriers to deprescribing inappropriate medication in older 
adults by general practitioners (GPs).(10-13) Patient belief may also influence medication adherence 
(taking medications as prescribed). Several studies across a wide variety of conditions, have 
highlighted that people with strong beliefs (as measured by the Beliefs about Medicines 
Questionnaire (14)) in the necessity of taking medication to maintain their health are more adherent 
to medications than those with higher levels of concern about medication.(15, 16) However, the 
majority of these studies have involved one group of medicines or specific illness groups, while 
comparatively few studies have examined beliefs about prescribed medication among older patients 
with polypharmacy in primary care.  Considering the important role beliefs may play in medication 
use, it is important to explore the beliefs of patients with polypharmacy.   
 
The aim of this study was to explore patients’ beliefs about and attitudes towards medication, within 
a population of community dwelling older patients with polypharmacy and explore factors which 
might influence medication beliefs.
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METHODS 
Study design 
A convergent parallel mixed-method design was adopted.(17) Secondary analysis of available 
quantitative and qualitative data was conducted separately (described below), and the findings 
triangulated during the interpretation stage.(17, 18) While quantitative and qualitative data were 
available on the majority of cases, a mixed methods matrix was not conducted due to missing 
data.(18) 
  
Context and study setting 
Data were obtained from OPTI-SCRIPT (OPTImizing PreSCRIbing for Older People in Primary 
Care, a clusTer randomized controlled trial), a pragmatic cluster randomised controlled trial 
conducted in Ireland. The trial involved 21 GP practices and 196 community dwelling patients aged ≥ 
70 years, with pre-existing potentially inappropriate prescribing. (19) The study found that a 
multifaceted intervention (incorporating academic detailing and GP-led medicines review) was 
effective in reducing potentially inappropriate prescribing in the intervention group (see Appendix 1 
and 2 for more detail). (19-21) The present study uses cross-sectional data collected at baseline from 
all participants (May 2012–February 2013), and qualitative data collected during the OPTI-SCRIPT 
process evaluation (January 2013- August 2013). (22)   
 
Quantitative data collection and analysis  
Medication data  
Medication data was collected through review of electronic or paper based patient charts, 
depending on the practice system. The number of repeat medications per participant (n=196) was 
recorded and classified according to the Anatomical Therapeutic Chemical classification system of 
the World Health Organization (WHO ATC). The prevalence of polypharmacy (≥5 regular medicines) 
and excessive polypharmacy (≥10 regular medicines) was calculated.(3) 
 
Questionnaires 
Demographic information and patients’ beliefs about medication were collected at baseline via 
postal questionnaire with telephone follow-up for non-responders. Participant beliefs were captured 
using the Beliefs about Medicines Questionnaire (BMQ). (14) The BMQ consists of a specific and a 
general part. The BMQ-Specific assesses patients’ beliefs about medication prescribed for them and 
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comprises two scales assessing personal beliefs about the necessity of prescribed medication for 
controlling illness and concerns about the potential adverse consequences of medications. The 
necessity-concern differential acts as a cost-benefit analysis, where patients weigh up the concerns 
(costs) they have about medication against their perception of their necessity (benefit). It is scored -
20 to 20 with positive results indicating the patient perceives the benefits outweigh the risks. The 
BMQ-General measures beliefs about medicines in general. Respondents indicate their degree of 
agreement with each statement about medicines on a Likert scale, ranging from 1 (strongly disagree) 
to 5 (strongly agree). Scores obtained for the individual items within each scale are summed to give 
a scale score. Higher scores indicate stronger beliefs in the concepts represented by the scale.  
 
Participants were excluded if more than two items on the BMQ were missing. Mean and median 
scores for the four subscales, and the necessity-concerns differential were calculated. The separate 
necessity and concern scales were divided at the scale midpoint to create four attitudinal groups, as 
used in previous studies (23): (a) skeptical (low necessity, high concerns); (b) indifferent (low 
necessity, low concerns); (c) ambivalent (high necessity, high concerns); and (d) accepting (high 
necessity, low concerns).  Multivariable regression analyses adjusting for demographic factors were 
used to study associations between BMQ subscales and participant characteristics with the 
subscales as dependent variables. All analysis was conducted using STATA Version 13 (StataCorp, 
Texas, USA).   
 
Qualitative data collection and analysis   
Qualitative data were collected from one-to-one semi-structured interviews with a purposive sample 
of participants in the intervention arm of the OPTI-SCRIPT study, to ensure coverage across GP 
practices, patient gender, and types of medications. All interviews were conducted via telephone by 
one interviewer (BC) and were audio recorded (on loud speaker).  The interview topic guide 
(Appendix 3) covered aspects of the trial evaluation, and the following broad sections were pertinent 
to this current study: participants’ perceptions of their medications and experiences of GP 
consultations (Table 1). 
All interviews were transcribed verbatim by one interviewer (BC) and analysed using a thematic 
analysis following a six-step process. (24) Two researchers (BC, JAC) independently reviewed the 
individual transcripts several times to familiarise themselves with the data. Small sections of data 
were assigned a code that summarised the content. Codes with common features were grouped 
together in emerging themes, before finally being assigned to overarching themes.(24) Quotations 
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were used as exemplars of key themes.  NVivo 10 was used to assist with organizing the data for 
analysis. All participant data were pseudo-anonymised by assignment of a unique study ID.  
RESULTS 
Characteristics of participants  
Of the 196 participants aged ≥70 in the OPTI-SCRIPT study, 54% were male and the mean age was 
76.7 (SD 4.9) years (Table 2). Recruited patients were demographically similar to the general 
population of those aged 70 and over in Ireland (Appendix 2). A total of 1,862 drugs were recorded 
with a mean of 9.5 (SD 4.1) per person. Just under half (46%) of participants had excessive 
polypharmacy (≥10 medicines). Cardiovascular medication was the most frequently prescribed 
medication category (26.9%), the majority of which were statins, followed by drugs for the 
alimentary tract & metabolism (18.2%) (Appendix 4).  
 
Most participants (96.3%) believed in the necessity of their medication for maintaining health (i.e. 
had scores greater than the scale midpoint). Overall, 33.9% reported concerns about potential 
adverse consequences of taking their medication (i.e. scores greater than the scale midpoint). For 
the vast majority (94%), the difference between the necessity and concern scores was positive, 
indicating strong beliefs that the benefits of their medications outweighed the costs (Table 3). When 
participants were categorised by belief group, the majority were found to be either accepting 
(63.4%) or ambivalent (32.6%) towards their medication (Figure 1).  
 
Most participants believed that medicines were generally beneficial. Only 3% indicated a high belief 
(i.e. had scores greater than the scale midpoint) that medicines were generally harmful and just over 
5% had a high belief (i.e. had scores greater than the scale midpoint) that medicines were generally 
overused (Table 3).  
 
Results from multivariate regression analysis with the four BMQ subscales as the dependent 
variables, adjusting for demographic factors  (Table 4), demonstrated an increase in the number of 
repeat medications was significantly associated with an increased score on the necessity subscale 
(0.23, 95% CI 0.11-0.35, p<0.01).  
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Participant views on medication 
From 14 patients approached, 11 participants were interviewed, 54% of whom were male, with a 
mean age of 77 years. Interviews ranged from 6.21 to 20.27 minutes (Table 2). Of the 11 
participants, six (54.5%) were categorised as accepting, three (27.3%) were ambivalent and two 
(18.2%) had insufficient data to calculate based on baseline BMQ. From the interview data, three 
main themes emerged: necessity and concern conflict, knowledge of medications, relationships with 
health care providers.      
 
Necessity and concern conflict   
The majority of participants reported that they accepted medications were necessary to “keep 
you ticking over” (P655) and “keeping the engine running” (P161). Some participants were however 
concerned about long-term medication use and potential adverse side-effects, particularly for 
medications prescribed for prevention of future problems:  
“Well maybe, you know you read the leaflets, but I mean you read them and there is 
everything on it, you know, there could be side-effects, and they just like have them a hundred 
and one, and you say to yourself, Oh my God. If you get them (medication) for blood pressure, 
they say they could cause your blood pressure to go up, they could cause heart attacks, you 
know all this. So you don’t know whether you are doing right or wrong having a particular 
medication, I don’t know.” (P74) 
 
“Well, there is one worry that you do have at the back of your mind, that when, I’m so long on 
the tablets, you know what I mean, and there might be something happening and I don’t know 
about it because I feel OK, but you don’t know.” (P125) 
 
Medications prescribed for symptomatic relief of symptoms were viewed as beneficial and more 
readily accepted, often despite potential side-effects: 
 
“I should say, I didn’t take them (medication) one particular morning and didn’t take the tablet 
that night, but by God, I knew all about it the next day. I didn’t realise I really relied on those 
tablets as much as I am. And I’d say if I didn’t have those I don’t know where I would be.” 
(P1315) 
 
“COPD [Chronic obstructive pulmonary disease] is a nuisance but you just have to take the old 
inhalers and that. I don’t like being on steroids. Recently, as you know I’ve osteoarthritis, and I 
was in recently getting injections in my back, for the pain in my back you know, and you know 
the little thing they put in your arm, to knock you out, that thing, it tore the skin, and just the 
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eh, anaesthetist who was putting, he said ‘you must be on steroids’, it makes my skin very thin. 
So that’s the bad effect of the steroid, but then, if I need them to breath! Catch 22, isn’t it.” 
(P655) 
   
 
Knowledge of medications 
Participants reported variation in the level of knowledge about medications prescribed for them. 
Some participants were well-informed and comfortable discussing their medications, while others 
expressed a lower level of understanding:  
“… coz we really don’t know what we are taking half the time…” (P125) 
 
“So the new tablet now, I don’t know the name of it, I do call them by the colours, I do be 
telling him, the pink one and the green one and the yellow one and the white one…” (P639) 
 
Relationships with health care providers  
The majority of participants described positive relationships with their GPs, citing satisfactory 
aspects of consultation style, including approachability, being listened to, and feeling comfortable: 
   
“I would say, I find that practice very approachable, both Dr X and Dr Y, they’re both, you can 
just speak to them you know, like a friend. Anything I’d have to say I could talk freely with 
them, you know, there is no kinda, doctor – patient where you are nearly afraid as we were 
years ago, there’s nothing like that, I feel very comfortable with them I suppose is the word.” 
(P655) 
 
“I always find it rewarding because he [GP] is a very knowledgeable man and he is very 
dedicated.” (P1347) 
 
GPs perceived as supportive and engaged, fostered a sense of trust and participants were confident 
they would make the right treatment decisions, even where reviewing or stopping medications was 
concerned: 
“I trust Dr X, you know with anything she does, you know she only gives me something for a 
reason, she doesn’t just give me it for the sake of it, ‘Oh I’ll have to get rid of her’ or something 
like that, no. She is very thorough and very conscientious.” (P2338) 
 
“Well I mean the doctor said it to me you know, ‘O I don’t like you taking Difene’, I say why, 
‘because it’s very hard on the stomach’ you know, and I think it’s the kidneys or the liver or 
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something, you know, I accept what they tell me. Well that’s what we go to the doctor for isn’t 
it – to be told what’s good for your body.” (P655) 
 
 
 “I think that is what you would be looking for [review of medication], because nobody wants 
to take more medications than they need to.” (P1345) 
 
Familiarity was a key element, with established relationships and positive past experiences 
increasing patient confidence:  
“I go with him (GP). He’s been very good over the years and I’m always led by him. What he says 
I’ll take his word for it as right.” (P125) 
 
“I have a very good GP, Dr. Y and he has a few assistants there, and eh, they’re all very 
attentive there I must say, all very very good and he’s available at all times, you know, all you 
do is lift the phone and you get an appointment.” (P639) 
 
Some participants did express dissatisfaction about aspects of how medications were prescribed, in 
terms of information provided, particularly where hospital prescribing was concerned:  
“You see people of my age going in to the pharmacist and coming away with a big parcel of 
stuff, now I wouldn’t know, their general, whether they need all them things or not, but I 
would get the impression that their not keeping, you know, there is probably no need for a lot 
of the stuff that their taking you know.” (P1616) 
 
“I’m saying specifically if you go, you go to the hospital rather than your doctor, with 
something that needs to be done up in the hospital, they treat you, and they say well go on 
this, you know, do whatever, but they never tell you how long, and you stay on the thing then 
for, indefinitely like.” (P74)   
 
Three interviewees spontaneously discussed the role of pharmacists in prescribing, reporting 
positive interactions, particularly citing helpful innovations they provided such as pill boxes: 
 
“And I now I have got these things, they do it all in the chemist with these packs, it’s plastic like 
a tray, and it’s brilliant, and I’m quite happy with that.” (P2338) 
 
  
11 
 
DISCUSSION 
Summary  
Using a mixed methods approach, this study among older community dwelling patients with 
polypharmacy, highlighted that the majority believed in the necessity of their medication. However, 
this belief was underscored by complex attitudes. 
 
Comparison with existing literature 
Older patients with multimorbidity (presence of >1 chronic health condition(25)) and polypharmacy 
may be critical of taking numerous medications and conceptualise this as a burden.(26, 27) Similar to 
a previous Swedish study (28), the majority of our participants (94%) had strong beliefs in their 
benefits, however, approximately one-third of participants had strong concerns. For the majority, 
belief in necessity outweighed any concerns, similar to patterns observed in a frail elderly 
population.(29) This highlights the complexity of attitudes to prescription medication use, as people 
possess co-existing accounts of positive and negative attitudes to their medications. (26, 30) Patients 
may be grateful for the symptom relief provided, but many prescribed medications are used to 
extend life or for secondary prevention of disease. The qualitative findings highlighted that these 
medications were harder for patients to accept. Patients are expected to take these medications 
long-term, often without experiencing any immediate tangible benefit, but being aware of the 
potential risk of adverse effects, thereby creating uncertainty about the total overall benefit.  
 
Despite some patients potentially holding negative views towards medications, evidence suggests 
most patients adapt to long-term medication use. (26, 31, 32) Our patient population were primarily 
categorised as accepting (63%).  The multivariable regression revealed that as the number of 
medications increased, so did the score on the BMQ necessity subscale, indicating that as this 
number increased, beliefs in the necessity became stronger. Patients described their medications as 
necessary to keep them ‘ticking over’, indicating a practical acceptance. At the same time however, 
some participants reported poor knowledge of their medications, a common trait among patients 
taking multiple drugs, and older people in general tend to have poorer health literacy. (28, 33, 34) 
This highlights the complex interplay of strong beliefs in the context of limited knowledge.  Indeed, a 
previous study involving frail older patients found no relationship between strong beliefs and 
medication knowledge.(29) Despite having concerns and reporting poor knowledge, the majority of 
our participants were accepting and reported a strong belief in the necessity of medications. One 
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explanation for this paradoxical position may lie within the qualitative findings on the doctor-patient 
relationship –specifically trust.   
 
Interpersonal trust (between patient and clinician) is a key element of the patient–doctor 
relationship, one particularly valued by older patients.(35-38) Our results highlight that for patients 
with polypharmacy, medication taking is often characterised by uncertainty, elements of risk, and 
information asymmetry between patient and GP (i.e. GPs have more information than patients, 
creating an imbalance of power). Trust is necessary in such conditions of uncertainty as it reduces 
complexity, allowing people to make decisions. (39, 40) In this context, trust in the GP may enable 
patients to negotiate the complexity and uncertainty of polypharmacy. Trust can influence patients’ 
attitudes of medications, with patients likely to develop negative attitudes of medications where 
their trust in a prescriber is negatively influenced.(30, 32, 41) Along with lack of guidelines and the 
involvement of multiple prescribers, patients’ strong beliefs in medicines are often reported as 
important barriers to deprescribing by GPs.(10, 11) However, strong beliefs exist against a backdrop 
of positive and negative attitudes. Our participants had strong beliefs in medicine, yet also expressed 
willingness to trial stopping medications, similar to other cohorts. (42) This willingness may arise 
through interpersonal trust as evidence suggests that patients report willingness to trial cessation of 
medications when recommended a physician they trust. (13)  
 
Strengths and limitations  
Combining qualitative and qualitative data allows a richer analysis. Participants completed 
questionnaires without a researcher present which may have decreased responder bias. Despite 
contacting participants to obtain missing data, not all participants answered the BMQ in full. This 
was taken into account in the analysis, but may have impacted on the results. The qualitative data is 
limited as it was obtained as part of a larger process evaluation of the OPTI-SCRIPT trial. 
Consequently, the sample was limited to  trial participants who may not be representative of all 
older patients,  the topic guide was not designed to explore issues of polypharmacy specifically and 
interviews were shorter on average (14 minutes) than may be expected. While the themes 
presented here emerged strongly from the data, arguably, a more detailed interview may have 
produced a more nuanced account.  Overall, our results are consistent with limited previous 
qualitative studies in this area, increasing confidence in the findings.  
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Implications for research and practice 
In light of the increased prevalence of polypharmacy, and associated adverse consequences, it is 
imperative to develop effective interventions to improve appropriate polypharmacy and patient 
outcomes. (9, 16) Increasingly, there is a focus on deprescribing, with recent reviews stressing the 
importance of shared decision making.(43, 44) Patients’ strong beliefs in medicines are often 
reported as important barriers to deprescribing by GPs.(10, 11) However, our findings highlight that 
strong beliefs often mask a complex interplay of positive and negative attitudes, in the context of 
limited knowledge and a willingness to stop medications. Patients’ beliefs and attitudes about 
medications may be influenced by the patient-doctor relationship. Patient trust may facilitate a 
willingness to tolerate polypharmacy in a context of uncertainty, but it may equally influence 
patients’ willingness to deprescribe. Our study provides evidence supporting building strong 
relationships with patients with complex multimorbidity and polypharmacy to enhance 
deprescribing. (41) Practical strategies to achieve this include active identification of complex 
patients, and the adoption of a policy of continuity of care such as assigning these patients a named 
doctor. (25) Strategies that improve continuity of care may also reduce secondary care costs, 
particularly for the heaviest users of healthcare. (45) 
 
In conclusion, participants reported strong beliefs in medications with co-existing positive and 
negative attitudes. Furthermore, the patient–doctor relationship may influence beliefs and attitudes 
towards medicines and deprescribing.   
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Table 1 Broad prescribing-related interview questions 
Broad questions 
Could you tell me a little about your medications? 
   Prompts: what do you take; how many medicines; are your medicines 
important/necessary; why do you take them; are there any side effects  
Could you tell me how you feel about taking these medications?  
   Prompts: How does having to take your medicines impact on you  
Could you tell me a little about your interactions with your GP? 
  Prompts: How often do you see them; what do you discuss about your 
medications; what type of information about your medications do you get  
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Table 2 Characteristics of study sample (n=196) 
Characteristic n 
Male (%) 105 (53.6) 
Age (years) (%) 
70-75 
76-80 
81-85 
86-90 
91 + 
 
Mean (SD) 
Range  
 
94 (48.2) 
58 (29.7) 
35 (17.9) 
6 (3.1) 
2 (1.0) 
 
76.7 (4.9) 
70-94 
Marital status (%) 
Married/Cohabiting 
Widowed  
Single 
Divorced/separated 
 
107 (55.4) 
58 (29.7) 
24 (12.3) 
5 (2.6) 
Educational level (%) 
None or low  
Secondary education 
Tertiary education  
 
67 (35.1) 
85 (44.5) 
39 (20.4) 
GMS card holder* (%) 183 (93.4) 
Repeat medications (%) 
≤ 5 
6-9 
≥ 10 
  
Mean (SD) 
Range 
 
34 (17.3) 
72 (36.7) 
90 (45.9) 
 
9.5 (4.1) 
3-23 
Mean (SD) 
potentially 
inappropriate 
prescriptions 
1.35 (0.62) 
Interview participants  
Male (%) 
Mean age (SD) 
 
Repeat medications (%) 
6-9 
≥ 10 
 
Mean (SD) 
Range 
11 
6 (54.5) 
77 (3.9) 
 
 
4 (36.4) 
7 (63.6) 
 
11.8 (4.4) 
7-20 
* GMS General Medical Services card: GMS is a means tested scheme which entitles those who qualify access 
to public health services, free of charge.  Approximately 97% of those aged over 70 years are eligible.   
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Table 3 Patients' beliefs about medicines 
BMQ Subscale  Mean 
score (SD) 
Median  
(Range) 
Number (%) 
above the scale 
midpoint  
Necessity^ 19.7 (3.3) 20 (8 to 25) 180 (96.3%) 
Concerns^ 12.8 (3.9) 12 (5 to 22) 62 (33.9%) 
Necessity-concern differentialƗ  6.9 (5.3) 69 (-4 to 20) 94% 
General overuse* 10.9 (2.9) 11 (4 to 20) 10 (5.4%) 
General harm* 9.8 (2.9) 10 (4 to 20) 5 (2.7%) 
^Scale from 5 to 25 where high scores indicate strong belief  
Ɨ Scale from -20 to 20 where positive scores indicate patient perceives benefits outweigh risks  
*Scale from 4 to 20 where high scores indicate negative attitude towards medicines 
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Table 4 Linear regression analysis of beliefs about medicines subscales and number of repeat medications  
BMQ Subscale  B* 95% 
confidence 
interval  
P value  
Necessity 0.23 (0.11, 0.35) p<0.01 
Concern 0.03 (-0.12, 0.17) p= 0.71 
Harm - 0.10 (-0.21, 0.00) p = 0.05 
Overuse - 0.11 (-0.22, -0.11) p = 0.03 
*Adjusted for age, gender, educational level, marital status 
